Heart disease medication plays a critical role in managing and preventing cardiovascular conditions. Understanding the various types, their mechanisms, and how they work can help people make informed ...

Heart disease continues to rank as the leading cause of death in the Black community, claiming thousands of lives annually. While lifestyle modifications remain foundational to heart health, modern ...

A new study led by a researcher at University College London (UCL) suggests that the anti-obesity drug semaglutide may reduce the risk of heart attacks and other serious cardiac events even when ...

Prophylactic cardiac treatment in DMD patients is associated with a 54% lower hazard of death, highlighting its potential survival benefit. Only 27.7% of DMD patients received prophylactic cardiac ...

Dementia prevention is a critical area of research, as experts want to understand what people can do to decrease dementia risk. A recent study found that more than 5 years of taking medications like ...

Secondary prevention medications for cardiovascular diseases (CVD) are underused globally and additional strategies to increase their use are needed to improve CVD management and reduce premature ...

New research finds statins benefit adults with type 2 diabetes across all heart-risk levels, reducing deaths and serious ...

Real-world data show semaglutide (Ozempic/Wegovy) and tirzepatide (Mounjaro/Zepbound) are linked with lower risk of major ...

Please provide your email address to receive an email when new articles are posted on . Lipid-lowering and antidiabetic medication use decreased in patients who underwent bariatric surgery vs. those ...

Cytokinetics Inc. won US approval for a drug to treat a deadly heart condition, posing a potential threat to sales of a ...

Providing medications for chronic diseases—for example, cholesterol-lowering, blood pressure and diabetes medications—free of charge for three years did not have a significant impact on serious health ...